In the ongoing quest to alleviate the burden of depression, a significant breakthrough has emerged in the form of TMS Therapy, now available to patients seeking alternative treatments. TMS, or transcranial magnetic stimulation, offers a non-invasive and non-systemic approach, particularly beneficial for those who haven't found relief with traditional antidepressant treatments. This innovative therapy has gained FDA clearance, marking a pivotal moment in mental health treatment.
Prime Psychiatry stands at the forefront of this advancement, utilizing the cutting-edge Magstim TMS Therapy system. This state-of-the-art device is specifically designed for the TMS procedure, ensuring a high standard of care. Each session under this therapy is concise, lasting only 19 minutes, and is conducted five days a week. A typical treatment course spans 36 sessions, spread over 6 to 9 weeks, allowing for a thorough and effective treatment period.
Beyond TMS Therapy, Prime Psychiatry is committed to offering a comprehensive range of mental health services. Their portfolio includes Spravato Treatments, Medication Management, Counseling Services, Psychiatric Services, Substance Abuse Treatment, and specialized care in Child & Adolescent Mental Health. This diverse array of services ensures that individual needs are met with the utmost care and professionalism.
Accessibility is a key component of Prime Psychiatry's service model. Through telepsychiatry, patients can access these vital services with ease, ensuring that professional help is just a phone call away. The dedicated staff at Prime Psychiatry is readily available during office hours to assist with inquiries, provide information, or schedule appointments, making the journey towards mental wellness as smooth and supportive as possible.
This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™
The reference URL for this press release is located here New Treatment Offers Hope for Patients Battling Depression: Introducing TMS Therapy.